SCHEMBL17405294

SCHEMBL17405294

CCc1nc2ccccc2n1-c1ccccc1-n1c2ccccc2c2c3c4ccccc4oc3c3c(c4ccccc4n3-c3ccccc3)c21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
KMT2A Q03164 1/20 0.39
POLB P06746 3/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
RECQL P46063 2/20 0.38
PSMD14 O00487 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
PDE10A Q9Y233 2/20 0.36
RAB9A P51151 1/20 0.36
LMNA P02545 1/20 0.35
NTRK1 P04629 1/20 0.35
NTRK2 Q16620 1/20 0.35
CYP1A2 P05177 1/20 0.35
CA12 O43570 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17405276 0.94 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2KDM4EMEN1MAPT
SCHEMBL17405304 0.93 RAB9A (0.41) ALDH1A1SMN1; SMN2MEN1MAPTKMT2A
SCHEMBL17405257 0.91 SMN1; SMN2 (0.43) ALDH1A1SMN1; SMN2KDM4EMEN1MAPT
SCHEMBL17405283 0.89 MAPK1 (0.49) ALDH1A1SMN1; SMN2KDM4EMEN1MAPT
SCHEMBL17405299 0.87 RAB9A (0.45) ALDH1A1SMN1; SMN2MEN1MAPTKMT2A
SCHEMBL17405293 0.86 ESR1 (0.43) ALDH1A1SMN1; SMN2KDM4EMEN1MAPT
SCHEMBL17405285 0.85 MAPK1 (0.54) ALDH1A1SMN1; SMN2KDM4EMEN1MAPT
SCHEMBL17405255 0.85 USP2 (0.44) ALDH1A1SMN1; SMN2MEN1MAPTKMT2A
SCHEMBL17405308 0.84 RECQL (0.43) ALDH1A1SMN1; SMN2KDM4EMEN1MAPT
SCHEMBL17405258 0.83 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2KDM4EMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9887367-B2 Heterocyclic compound, material for organic electroluminescent elements using same, organic electroluminescent element using same, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2018-02-06 US disclosed
US-9887367-B2 Heterocyclic compound, material for organic electroluminescent elements using same, organic electroluminescent element using same, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2018-02-06 US disclosed
US-20160005977-A1 HETEROCYCLIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME, ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-01-07 US disclosed
US-20160005977-A1 HETEROCYCLIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME, ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160005977-A1 HETEROCYCLIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME, ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME, AND ELECTRONIC DEVICE ODC1, NOTUM, OR10J3 ALDH1A1 1348/4885SMN1; SMN2 3232/4885KDM4E 1073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.